Annual Report 2019 - Atos Medical
1Annual Report 2019Lary 1 ABATOS MEDICAL – ANNUAL REPORT 2019
2Atos Medical in briefHighlights 2019Words from the CEO456We listenOur product portfolioOur customers910We inspireOur global reachOur strategy1314We focusOur innovation leadership 17We engagePeople make the difference 19Sustainability20Corporate GovernanceBoard of directorsLeadership teamRisk managementDirectors’ ReportThe GroupParent companyAuditor’s ReportAdjusted EBITDA bridge222324252830616769We are Atos MedicalAtos Medical was born out of a desire to make life easier for people living with a neck stoma. Sinceour foundation in 1986, we have cemented ourselves as the leaders in neck stoma care, with a worldleading position in laryngectomy care.Today, Atos Medical continues to serve the needs of more than 100,000 people with a neck stomaglobally. We want to remain at the forefront and this involves first-rate product development, basedon profound clinical research and customer insights, as well as customer care, with education of bothprofessionals and patients. These are integral parts of our business.This Annual Report is issued by Lary 1 AB. Lary 1 AB is the top parent company in a group of companies referred to as the Atos Medical Group. In this report, we use “Atos Medical”, “us”, “the company” etc.,as synonyms for the Group.
3We are passionate about making life easier for peopleliving with a neck stoma, by providing personalized careand innovative solutions.ATOS MEDICAL – ANNUAL REPORT 2019
4Atos Medical in briefOur values– We careOur values represent commitmentsto all our stakeholders. By livingour values, we demonstrate that wecare about our customers andeach other. This makes us proudto serve our customers every day.Our portfolioOur customersOur strategyOur comprehensive portfolio hasevolved over the last 30 years togive a voice to people whobreathe through a stoma.In recent years we have investedin understanding our customers’needs and gaining an insightinto how to better serve them.Read more on page 9.Read more on pages 10–11.In 2019 we launched a newstrategy “Succeeding throughPersonalized Care”, further emphasizing our continued strongcustomer centric focus. A deepinsight into our customers’ situation enables us to address theneeds of each individual customerand it facilitates a strong collaboration with health care professionals, so they can help theirpatients breathe, speak and live.Read more on pages 14–15.ATOS MEDICAL – ANNUAL REPORT 2019
8%21%5Highlights 2019Revenue by segmentRevenue by geography7%9%28%81%23%21%19%23%tsSouth EuropeLaryngectomy CareNew MarketsSouth EuropeicaNorth EuropeTracheostomy CareNorth AmericaNorth EuropeOtherCentral EuropeopeSEKm201920182017Revenue1 7361 6081 267295186145EBIT9%12%19%Financial summary7%12% EBITDAAdjusted671EBITDA125744712392594144681% %Adjusted EBITDA38,7%35,7%37,2%EBITDA %34,2%27,7%30,9%Reported growth of 8% in 2019, organic growth in comparable currency is 6%Laryngectomy CareTracheostomyCare1) AdjustedEBITDA and EBITDA for 2019 is positively affected by the IFRS16 implementationOther with SEK 37m2) djusted EBITDA has been restated compared to annual report 2018 as non comparableAitems have been reduced by SEK 36m in 2018 and by SEK 33m in 2017 which has berestated to ordinary costs2019 was a successful year where we enhanced the strong commitmentto our customers and we delivered double-digit growth in our Larybusiness. With a new Management in place, we invested in strengtheningour foundation, for a sustainable business model and a strong future.”Lars Frederiksen, ChairmanATOS MEDICAL – ANNUAL REPORT 2019
6Creating customervalue for astronger futureOur future success will come from prioritizingcustomer needs in everything we do and I amexcited about the strong business potential.ATOS MEDICAL – ANNUAL REPORT 2019
72019 was a remarkable year for Atos MedicalJoining Atos Medical in March 2019, my firstyear as the CEO has given me valuable insights into the challenges our customers facefollowing a laryngectomy. The appreciationby patients and health care professionals ofthe difference Atos Medical makes for people living with a neck stoma makes meproud, and drives the ambition to securethat many more have access to care.In recent years, we have experienced stronggrowth, and the laryngectomy business nowrepresent more than 80% of our total revenue.In 2019, we launched our new strategy “Succeeding through Personalized Care. Our aimis to leverage our strong direct-to-consumerset-up, while optimizing the balance betweendirect support to users and assistance tohealth care professionals.We will join forces to enhance the quality ofhow customers breathe, speak and live.our strengthened customer-centric purpose,“Breathing – Speaking – Living”, which emphasizes our commitment to better customercare, and highlights that we provide muchmore than giving voice.experienced and diverse Global ManagementTeam that leads and sets the global directionfor a promising future, and who thrive tobring our unique purpose and values to lifein our culture every day.Investing to accelerate growthLooking aheadWe are 800 colleagues in 22 countries, whoare engaged and passionate about servingan increasing number of customers. Totalrevenue increased to SEK 1,7bn at 8%growth, and our core business, Laryngectomy, grew 10% organically, especially drivenby strong growth in new markets, like Brazil and Australia and Southern Europe.Our future success will come from prioritizing customer needs in everything we do.Combining a deep expertise in serving people living with a neck stoma, our innovationmindset and our skilled and engagedemployees makes me excited about thefuture. We have many attractive opportunities in existing and new markets and opportunities in high potential adjacent businessareas. I look forward to continuing our important journey, creating a prosperous andsustainable future.We are constantly challenging ourselves toimprove how we serve our customers. In 2019,we have continued to invest in buildingcapabilities and strengthening our businessfoundation. Our key focus is to build a scalable, customer-oriented and cost-efficientset-up, where we also leverage the digitalopportunities.Our commitment to the communityCustomers remain in the center of everythingwe do. We have 30 years’ experience in ourfield, our people engage every day directlywith users and in order to better understandtheir needs, we conducted a global in-depthstudy of 1,800 laryngectomees. All this givesus a lot of insights, which we actively use toguide ground-breaking innovation and personalized care. I am excited to introduceProfitability continues to improve with a reported EBITDA of SEK 594m or 34% EBITDAmargin an increase of 7%-points, despitesignificant investments in strengthening ourfoundation.In 2019, we strengthened the organization,our capabilities and leadership. We welcomedalmost 200 new colleagues and promoted50 talented colleagues. We have formed anA sincere thank you to all my colleagues,who are bringing our values to live whenserving customers every day. On behalf ofAtos Medical’s Board of Directors, Management and employees, I would like to thankcustomers and stakeholders for the strongpartnership and collaboration in 2019.Britt Meelby JensenCEOATOS MEDICAL – ANNUAL REPORT 2019
8Working as an Speech therapist, myjob is about communication, humanrelationships and empathy. I’ve been workingwith Atos for 12 years and they are alwaysthere to answer my questions. I also feelcomfortable asking them to come and meetmy patients, because I know they are respectful. Together we can always find a solution.”Stéphanie Poulain, Speech therapistBordeaux, FranceWe listenAt Atos Medical, we are open-mindedand curious. We actively seek to learnfrom each other and our customers.We use the understanding we gain tochallenge each other to always improve.ATOS MEDICAL – ANNUAL REPORT 2019
9Our product portfolio– continuous improvement for better careOur product portfolio has developed over the last 30 years to give a voice to people who breathe through a stoma.The Provox range enables people to speakafter a total laryngectomy, despite havingno voice box. It also allows people to restoretheir lung health while breathing throughtheir stoma day and night.Over the decades, clinicians and users haveincreasingly recognized the strong benefitsand life changing impact of voice and lungrehabilitation. Typically, people undergo atotal laryngectomy following larynx cancer orhypopharyngeal cancer, also known as throatcancer, while other indications such as humanpapillomavirus (HPV) are on the rise.Products to suit different needsTo restore voice and lung health, the Provoxrange offers different voice prostheses (VPs)for speaking and options for breathing throughHeat and Moisture Exchangers (HMEs). Whilethe first Provox voice prosthesis was developedand launched in the 1990s, today, the Provoxrange offers several voice prostheses to suitdifferent needs and clinical settings.Following user demand, the HME range hasdeveloped into a portfolio consisting of HMEsfor different situations and times of the day.All HMEs are attached with an adhesive orwith an alternative device such as a tube tocover the stoma and provide a sufficient seal.We also provide various accessories such ascleaning devices and skin products to care forthe stoma and the skin around the stoma,and to ensure correct function and optimalperformance of the devices.products, such as tracheostomy tubes,speaking valves and HMEs. With a broadertracheostomy assortment, we will increaseour ability to help more people breathingthrough a tracheostoma to achieve a higherquality of life.Full product range for tracheostomy careIn connection with the acquisition of Heimomedin 2018 our product portfolio was expandedwith a wide range of tracheostomy (trach)Total laryngectomy is a life changing procedureleading to permanent changes in speaking andbreathing. Our product portfolio restores theability to speak and helps the user to breathebetter after a total laryngectomy.Before total laryngectomyAfter total laryngectomyAfter total laryngectomy, using Provox productsATOS MEDICAL – ANNUAL REPORT 2019
10Our customers– understanding the needs for better carePilar’s storyPilar is 54 years old. She lives in Barcelona, hastwo daughters and works as a dance teacher.Before her surgery Pilar really enjoyed her life,spending a lot of time with her friends and family and on the dance floor.Two years ago, Pilar was diagnosed with cancer,which was a big blow to her and her family. Despiteher physician attempting to avoid surgery byputting her through chemo- and radiotherapy, itATOS MEDICAL – ANNUAL REPORT 2019was eventually decided that she needed a totallaryngectomy. Having gone through a difficult recovery process with lots of ups-and-downs, Pilaris now living a very social life. By sharing her story and experiences with fellow users, Pilar is partof the Atos Medical community. She loves dancing and teaches different classes. “I feel that Ihave been given a second chance,” she says.“I enjoy my life; and thanks to my new voice,I can continue living it.”
11Pilar’s journey through total laryngectomy recovery – like that of most laryngectomees – took twists and turns as she moved through thefour phasesSurgeryIn hospitalLocationUser phaseAt homeGetting Ready“It was tough, and I felt very badafter the chemo- and radiotherapywhen I realized I had to undergo atotal laryngectomy.”Gaining ControlEstablishing NormalLiving wellComing home was traumatic, not just forPilar but also for her family. She had a lotof questions that worried her, causing alot of anxiety and restlessness. She wasvery scared of coughing and not beingable to breathe; these kind of concernswere constantly with her.With help from Atos Medical’s SpeechTherapy Service, Pilar learned to use hernew voice, breathe properly, coordinate themovement of her new way of speaking andto articulate better so that people couldunderstand her more easily.Pilar is enjoying life today withher two daughters. She lovesdancing and does what shewants, using a suite of productsto adapt to different situations.“Acceptance is perhaps the mostdifficult of the stages, but it is vitalto continue with your life.”“My first questiondirectly after surgerywas ‘Can I speakagain?’. At that time,I didn’t think aboutanything else.”“I am a normal personwith some difficulties.Like everyone else.”Pilar had chemo-and radiotherapy thatunfortunately couldn’t cure her disease.Pilar had a lot of questions when she wasinformed that she would need a totallaryngectomy. She went to a Lary club torequest information about the rehabilitationprocess. At the club, it was recommended shevisit Atos Medical’s Speech Therapy Service.“I use Provox XtraFlow duringthe day, it’s best for me whenI’m dancing. During the eveningand night when I’m relaxing athome, I switch to ProvoxXtraMoist.”ATOS MEDICAL – ANNUAL REPORT 2019
12We inspireAt Atos Medical, we work with passion and dedication.We have ambitious goals and set the highest standardsfor ourselves. We aim to offer a compelling picture of thefuture that motivates others to take action.Every day I go home inspired when I have visited “my” customers athome or have spoken to them at a ‘My Voice Meeting’. If I realize that Ican help them by giving the right explanation about the use and diversity ofour Provox products, which improves their quality of life, my day has been asuccess! Together with the healthcare professional, I am building an improvedfuture for our users.”Joleen Heymeijer, Product SpecialistATOS MEDICAL – ANNUAL REPORT 2019
13Our global reachGlobal reach with directpresence in 22 countriesWe are directly present in 22 countries and inaddition to this we have exclusive distributorscovering more than 50 countries. Our staffcomprises one of the world’s largest ENTsales forces with 200 field representatives inaddition to a full scale Direct-to-Consumersetup with 200 FTEs.Direct presence through subsidiaryPresence through distributorATOS MEDICAL – ANNUAL REPORT 2019
14Our strategy – Succeeding through Personalized CareIn 2019, we launched our strategy “Succeeding through Personalized Care”, further emphasizing our continued patient and customercentric focus. Our updated strategy builds on a thorough understanding of our customers’ situation to make sure we address the needsof each individual customer that we serve.In addition, the strategy addresses the three main value drivers of the business: New Patient Acquisition – expanding the number of customers we serve Retention – retaining our customers for life Consumption – ensuring that our products are used compliantly and correctlyOur 2020 vision is built upon 3 strategic priorities with 7 supporting Must Win Battles:123Serve all lary patientsearly and maintainfor lifeExpand throughcontinuous productadvancementSecure strongfoundation foraccelerated growthATOS MEDICAL – ANNUAL REPORT 2019Engage with all lary patientsearly after surgeryPartner with clinicians to providebetter patient careRetain customers for lifethrough personalized careOptimize customer experience throughproduct usage and engagementAccelerate innovationleadershipBuild reliable and simple business processessupported by corporate infrastructureRetain engaged employees
15123Serve all lary patientsearly and maintainfor lifeExpand throughcontinuous productadvancementSecure strongfoundation foraccelerated growthWe engage with laryngectomized (lary) patients early in theirpatient journey, immediately before or after the surgery. Wesupport patients directly and we also work with clinicians,assisting them in their important role of taking active part inaccelerating their patients’ journey towards a high quality oflife after a total laryngectomy.During the past few years, we have invested in a Direct-to- consumer setup in all our markets and today interact withthousands of patients globally. We invest in improving ourengagements through our current channels, and we are expanding to new digital channels, to engage with our customersbased on their individual preferences. In 2019, we launchedour app and our investments in this area will continue in 2020.As we continue our growth journey, we depend on skilled andengaged employees as well as the right infrastructure ofprocesses and structures, to support this growth.We have colleagues with clinical expertise and experience andwe provide education and support in strong collaboration withclinicians, helping patients to achieve good product habits.In 2019, we increased our focus on building strong relationships with clinicians to ensure that patients receive the bestpossible care.a. Engage with all lary patients early after surgeryTo strengthen our market leader position, we strive to remainat the forefront of product innovation. We are continuing todevelop our pipeline of products and services, based on ourcustomer insights gained through decades of experience anda recently conducted global study of 1,800 laryngectomees.In 2019, we increased investments in our corporate infrastructureto get better access and transparency to our sales and customerdata. We continue this focus in 2020, to improve how weserve our customers.On the people side, we are investing in further improving ourworking environment, e.g. introducing our own “Leading theAtos Way” leadership development program. This is summarizedin the following two Must Win Battles:a. Optimize customer experience through productusage and engagementa. B uild reliable and simple business processessupported by corporate infrastructureb. Accelerate innovation leadershipb. R etain engaged employeesb. Partner with clinicians to provide better patient carec. Retain customers for life through personalized careThis new strategy sets the direction for our business in 2020 and beyond, and we believe it covers all aspectsrequired for our continued growth and market leadership, as it focuses on our main business driver, our customers.ATOS MEDICAL – ANNUAL REPORT 2019
16Our innovation teams focus on one singlething; What can we do better? As long asthere is a gap between the customers’ wishes, andwhat is actually on the market today, we willcontinue to fight to improve their quality of life.Innovations are the backbone of our existence.That is why we always work very closely with ourcustomers in everything we do.”Mikael Melefors, Vice President R&DWe focusAt Atos Medical, we choose to concentrate on the areaswhere we can bring the most value. Our choices are clearand transparent, and they help us achieve our ambitions.ATOS MEDICAL – ANNUAL REPORT 2019
17Our Innovation Leadership– delivering on customer needs2003Designed to prevent early leakage,Provox ActiValve was introduced asour most advanced voice prosthesisuntil then, incorporating magnets toprevent inadvertent opening.Giving peoplea voice since 1986201720141990Through R&D in cooperation with theNetherlands Cancer Institute, welaunched the first Provox voice prosthesis with the aim of improving voicerehabilitation after total laryngectomy.19862010For improved humidification and pulmonary rehabilitation, we introducedProvox XtraFlow and Provox XtraMoist HMEs for use in varioussituations.To give more people the freedom tospeak hands-free, we launched Provox FreeHands FlexiVoice , and withProvox StabiliBase we introducedour most advanced adhesive, providingadded stability when speakinghands-free.1996Starting in the mid-1990s, we began ourinternational expansion with subsidiaries in Europe and the United States.2012We fully committed ourselves to ourusers through community events,home visits, service calls and directdelivery across all our markets.2016We introduced Provox Coming Home to facilitate return from hospital forusers, and to present them and theircaregivers with sample products andrelevant information in an intuitive,step-by-step manner for guidanceand support.Atos Medical was founded in the southof Sweden by the brothers Gert andJan-Ove Persson.We launched Provox Luna , a nighttime solution to help users have betternights and prepare for better days.2018In connection with the acquisition ofHeimomedin 2018 our product portfolio was expanded with a wide rangeof tracheostomy products, such astracheostomy tubes, speaking valvesand HMEs.To meet growing demand, we expanded our R&D and manufacturingsite in Hörby, which now houses injection molding, assembly, tooling, qualitycontrol, packaging, warehousingand over 150 of our employees.ATOS MEDICAL – ANNUAL REPORT 2019
18We engageAt Atos Medical, we connect with ourstakeholders and involve them in ouractivities. We support and empower ourcustomers and each other every day.Respect and integrity are at the core ofeverything we do.I have been to over 20 Atos Medical’scommunity events, where I have access toeducation and other people who have gone throughthe same thing. My favorite part is seeing thehappiness after someone speaks hands-free for thefirst time. I would tell someone that is unsure aboutattending that they are not alone. You are not theonly one in the room that is a laryngectomee.Just be yourself and you can learn a lot!”Henry Childress, userATOS MEDICAL – ANNUAL REPORT 2019
19People make the differenceOur people are the strength and the key to our on-going success. We create the best customer experience and thereby successful businessthrough our 800 skilled and engaged employees worldwide. Our unique purpose is a strong driver for employee engagement, and astrong lever in attracting future talent.Atos Medical’s aspiration is to create a culture built on purpose, pride and sustainablegrowth. We believe that an open work environment and challenging roles and development opportunities all contribute to highemployee engagement. Working at AtosMedical means working within a diverse,global organization with incredible opportunities. During 2019, we promoted more than50 employees, a strong testament to ourtalent pool.other’s ideas, skills and experiences, within andacross teams, that truly innovative productsand solutions are created. One example isthe establishment of global cross functionaland cross territory teams, who have nowdeveloped new and improved tools andways of working.We strongly believe that our best work isco-created. It is only when we build on eachGreat leadership drives engagement, excellentcustomer experience and strong businessperformance. We are developing the “Leadingthe Atos Way” program, which will be launchedearly 2020. The program will establish aclear view of what great leadership at Atos80090%employeesworldwideare proud to workfor Atos MedicalMedical looks like and will give leadersacross all countries concrete tools to evolveand enhance the way they lead their teamstowards top performance.We listen to our people. The first global Employee Engagement Survey was launched in2018 and it is now embedded as a recurringevent at Atos Medical. We are very proud thatour overall satisfaction and motivation scorehas improved 4 points since last year, whichshows significant progression and brings usabove the global benchmark. This is a strongindicator of the value of listening to our employees and actively addressing their input.88%feel a sense ofcommitmentAtos Medical’s strong focus on developingleadership capabilities, enhancing engagement and evolving skills and new ways ofworking, will lead to a unique, high-performance culture built on pride, purpose andsustainable growth.50employeespromoted 2019ATOS MEDICAL – ANNUAL REPORT 2019
20SustainabilityAtos Medical is committed to sustainable and ethical businesspractices and we have adopted the UN Sustainable DevelopmentGoals (SDGs) as our framework. To seize the most material businessopportunities presented by the SDGs and to reduce risks, we defineour priorities based on an assessment of their positive and negative,current and potential impact on the SDGs across our value chains.To bolster our chance of meeting our goals, we integrate sustainability into our corebusiness and governance. We ensure that our goals have a strong link to our customer- centric purpose and strategy: to address the needs of our customers with personalizedcare, helping them breathe, speak, and live. Our sustainability framework is built on threepillars: People, Planet, and Business Ethics that support the UN 2030 Agenda for SustainableDevelopment, in particular the following SDGs:ATOS MEDICAL – ANNUAL REPORT 2019”We contribute to thewell-being of our customers through personalizedcare, empowering themto breathe, speak, andlive healthy lives””We provide a goodworkplace and equal opportunities; we systematically improve workingenvironment and worksafety in all of our organization”People”Our approach to environmental challenges isambitious and precautionary, and we seek touse resources efficiently”Planet”Respect and integrityare at the core ofeverything we do; and wework to promote ethicsand to reduce corruptionand bribery”Business Ethics
212019 ESG PerformanceWe work systematically with sustainability targets guided by the strategic priorities in the three pillars. We aim to ensure that our goalsinclude opportunities to make positive contributions to the SDGs as well as to reduce current and potential negative impacts.In 2019, we made progress in the following areas:Business EthicsPlanetPeopleWe updated our Code of Conduct to more clearly reflectour commitment to ethical interactions with both patientsand healthcare professionals, and show our commitmentto European and US industry ethics standardsWe renewed the energy mapping of our production sitein Sweden to identify good practices as well as opportunities for reducing our energy consumption levelsWe passed an unannounced MDSAP Audit re-certifyingus for compliance with ISO 13485, and regulationsin Australia, Brazil, Canada, Japan, the EU, and theUS, delivering on our promise for high quality, andsafe productsWe further strengthened our GDPR compliance efforts,building and training a network of Data ProtectionOfficers in our subsidiaries to deliver on our promise tosafeguard our customers’ personal dataWe rolled all distributors into our due diligence system todetect and prevent corruption and unethical behaviorin our distribution chainWe carried through initiatives to recycle all packagingmaterials to deliver on our pledge to use resourcesresponsiblyWe followed through on our plan for moving from parcelto full pallet delivery, and from air freight to bulktransportation to reduce the environmental impact ofproduct freightWe further strengthened our GDPR compliance efforts,building and training a network of Data ProtectionOfficers in our subsidiaries to deliver on our pledge tosafeguard our customers’ personal dataWe took action based on the 2018 employee survey,and improved the 2019 score by 6%, being true to ourpromise for a good and inspiring workplaceOrganization and ReportingSustainability (ESG) activities are anchored with members of the Global Leadership Team, and overseen by the Risk, ESG, and Compliance Committee. Performance is monitored on definedKPIs, and is reported quarterly to the Audit Committee, while the Board of Directors assesses the strategic ESG priorities annually. Environmental, Social, and Governance risks are integratedin Atos Medical’s general risk reporting and risk management system, cf. p 25.The statutory Sustainability Report, which tracks concrete KPIs for 2019 and presents focus areas for 2020, of the Atos Medical Group in accordance with the Swedish Financial StatementsAct is available at www.atosmedical.comATOS MEDICAL – ANNUAL REPORT 2019
22Corporate GovernanceAtos Medical’s Corporate Governance processesare aimed at continuously directing, controlling,and improving strategy and decision-making,defining clear responsibilities and identifyingand evaluating opportunities and risks forthe Group. Our Governance processes arecentered around our purpose of making lifeeasier for people living with a neck stoma, byproviding personalized care and innovativesolutions. Corporate Governance is exercisedby our Shareholders, and the Group’s two-tiermanagement.ManagementShareholdersThe Board has six members, of whom four areelected by the shareholders and two by theemployees Sweden (cf. p. 23). All shareholder- elected members of the Board of Directorsserve for one-year-terms and may stand forre-election at each annual General Meeting.The Board convenes at least four times per year.The shareholders have ultimate authorityover the Company and exercise their rightsat the General Meeting, which approve theannual reports, resolve on any amendmentsto the Articles of Association, and elect boardmembers as well as the independent auditor.Atos’ two-tier management structure consistsof the Board of Directors (BoD) and the GlobalLeadership Team (GLT). The two bodies areseparate and have no overlapping members.The GLT oversees day-to-day management,while the BoD supervises the GLT and is responsible for the overall management andstrategic direction.ATOS MEDICAL – ANNUAL REPORT 2019Board of DirectorsBoard of DirectorsBoard CommitteesPAI Partners, a leading European private equityfirm, has been the majority shareholder of theAtos Medical Group since 2016. PAI is one ofthe oldest and most experienced firms inEuropean private equity, and is characterisedby an industrial approach to ownership combined with a sector-focused organisation.PAI provides companies with the financial andstrategic support required to pursue theirdevelopment and enhance strategic valuecreation. PAI manages and advises close to 14 billion of dedicated buyout funds. Since1994, PAI has completed 75 LBO transactionsin 11 European countries, representing circa 55billion in transaction value. PAI has 86 experienced professionals from 15 countries andteams in Paris, London, Luxembourg, Madrid,Milan, Munich, S
This Annual Report is issued by Lary 1 AB. Lary 1 AB is the top parent company in a group of companies referred to as the Atos Medical Group. In this report, we use “Atos Medical”, “us”, “the company” etc., as synonyms for the Group. Atos Medical in brief 4 Highlights 2019
makes it imperative to focus on employee wellbeing and retention, thus protecting Atos Medi-cal’s brand as an employer. By aligning the ESG risk assessment with the strategic planning and the overall Enterprise Risk Management processes Atos Medical ensures that their Environmental, Social and Governance activities
Trusted Partner for your Digital Journey 3/49 1. Activity Report 1.1. Atos in the first half of 2021 January The South Australian Government chose Atos as a strategic partner.
the book (ATOS readability level) and the length of the book (number of words). For example, the Berenstain Bears books, which are about 1,000 words long and have an average ATOS book level of 3.5, are 0.5-point books. Hank the Cowdog, which is about 23,000 words long and has an average ATOS book l
Atos is a leader in transactional services, both for payment and for fully outsourced CRM. Whenever a solution or process requires high volume transaction processing, often involving complex multi-party relationships, Atos is able to offer the service. Intelligent managed services infrastructure applications support 3
2019 Alfa Romeo Giulia 2019 BMW X7 2019 Alfa Romeo Stelvio 2019 BMW Z4 2019 Audi A3 2019 Buick Cascada 2019 Audi A4 2019 Buick Enclave 2019 Audi A5 2019 Buick Encore 2019 Audi A6 2019 Buick Envision 2019 Audi A7 2019 Buick LaCrosse 2019 Audi A8 2019 Buick Regal 2019 Audi Allroad
1 / NURSING ANNUAL REPORT 2019 SENTARA MARTHA JEFFERSON NURSING ANNUAL REPORT 2019. 2 / NURSING ANNUAL REPORT 2019 NURSING ANNUAL REPORT 2019 / 3 Johnsa Greene-Morris, MBA, MHA, BSN, RN, NE-BC . related to healthcare-associated infection prevention, serving as a resource to team members, and providing peer-to-peer coaching. The team met monthly
HONOUR BOARD VOLUNTEERS 2019 - CURRENT David Staniforth Boorowa 2019 Bruce Gruber Boorowa 2019 Lindsay Cosgrove Boorowa 2019 Dennis Osborne Boorowa 2019 John Cook Boorowa 2019 Sue Cook Boorowa 2019 Mick Hughes Boorowa 2019 Daryl Heath Boorowa 2019 Lesley Heath Boorowa 2019 Russell Good Boorowa 2019 John Peterson Boorowa 2019 Heather Bottomley Boorowa 2019 James Armstrong Boorowa 2019
AS 8 PROTEIN SYNTHESIS QUESTIONSHEET 10 (b) (i) genetic code on DNA is copied into mRNA; double helix of DNA unwinds (in region to be copied); complementary nucleotides line up along coding strand of DNA; A to U and C to G; assemble together to make a complementary strand of mRNA; under influence of RNA polymerase; mRNA unzips from DNA template and passes to ribosomes; max 5 (ii) ATP provides .
